Detailed answers about STRATEGIC CLINICAL TRIALS SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was STRATEGIC CLINICAL TRIALS SERVICES LIMITED founded?
STRATEGIC CLINICAL TRIALS SERVICES LIMITED was officially incorporated on 27 September 2024 and is registered under company number 15983311. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is STRATEGIC CLINICAL TRIALS SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of STRATEGIC CLINICAL TRIALS SERVICES LIMITED?
STRATEGIC CLINICAL TRIALS SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does STRATEGIC CLINICAL TRIALS SERVICES LIMITED do?
STRATEGIC CLINICAL TRIALS SERVICES LIMITED operates in the following sector: 70229 - Management consultancy activities other than financial management. This provides insight into the company's primary business activity and industry focus.
What is STRATEGIC CLINICAL TRIALS SERVICES LIMITED's registered address?
The registered office address of STRATEGIC CLINICAL TRIALS SERVICES LIMITED is 21 LARKMEAD, ASTLEY, MANCHESTER, UNITED KINGDOM, M29 7SU. This is the official address filed with Companies House for legal and statutory correspondence.
Is STRATEGIC CLINICAL TRIALS SERVICES LIMITED financially stable?
The most recent accounts for STRATEGIC CLINICAL TRIALS SERVICES LIMITED were made up to 30 September 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 June 2027.